India: Patent

This comprehensive newsletter examines landmark intellectual property decisions from Q2 2026, spanning trade mark disputes over deceptive similarity and prior use...

The June 2026 edition of Dentons Link Legal IP & Technology Newsletter examines the global intellectual property ecosystem's strong momentum, featuring record-high filings, AI-driven innovation surges, and pivotal rulings that reflect technological advancement and evolving regulatory priorities. From bizarre patent cases like motorized pasta forks to multimillion-dollar verdicts collapsed by procedural flaws, the newsletter explores landmark decisions in pharmaceutical patents, trademark enforcement, and AI

In Astral Ltd. v. M/s Astral Marketing Syndicate & Anr., CS (COMM) 294/2024, the Delhi High Court dismissed an application seeking rejection of the plaint for lack of territorial jurisdiction. The Court held that, at the stage of considering an objection under Order VII Rule 11 of the Code of Civil Procedure, the averments in the plaint must be accepted as true. It further observed that an interactive listing on a third-party platform such as Justdial, through which consumers can access product catalogues, initiate enquiries, and contact the Defendant, is sufficient to prima facie confer territorial jurisdiction in an internet-based trademark dispute.

From bizarre patents like miniature umbrellas for beverages and sideways swinging methods to high-stakes pharmaceutical disputes and celebrity image rights battles, this comprehensive intellectual property newsletter explores the intersection of innovation, law, and commerce. Discover how courts worldwide are reshaping trademark protection, patent validity standards, and copyright enforcement while navigating emerging challenges posed by artificial intelligence, deepfakes, and digital content platforms.

Every good business has some kind of story behind it, like real innovation. Sometimes it starts with a breakthrough invention, other times it’s more like a recognisable brand identity, proprietary software, or an iconic product layout.

India's new SHANTI Act, 2025 marks a significant shift in nuclear energy governance by conditionally allowing patents for inventions related to peaceful uses of nuclear energy and radiation. This legislative change opens opportunities for innovators in biotechnology and nuclear sectors while imposing specific disclosure requirements and restrictions on sensitive technologies.

Most enterprises entering India through a BOT structure spend weeks negotiating hiring plans, transition timelines, pricing models, and operational governance. Then the agreement gets signed, the build phase begins, and business heads assume the difficult part is over.

Semaglutide, sold under the blockbuster brands Ozempic and Wegovy, has become one of the most talked-about drugs in recent memory. It belongs to a class of medicines known as GLP-1 receptor agonists, which mimic a hormone that regulates appetite and blood sugar.

Green tech and clean energy innovations are no longer “optional extras” for the Indian economy—they are central to India’s climate commitments, energy security, and long-term industrial growth.